Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederesmo.org
ESMO News
Get the latest updates from ESMO News directly as they happen.
Follow now 76 followers
Latest posts
Last updated about 17 hours ago
FDA Approves Cemiplimab-rwlc for Adjuvant Treatment of Cutaneous Squamous Cell Carcinoma
about 17 hours ago
Evidence for efficacy is based on the results from the C-POST study
Significant PFS Improvement with Ibrutinib-Rituximab Compared to Immunochemotherapy in Previously Untreated Patients with Mantle Cell Lymphoma
4 days ago
Findings from the ENRICH study
EMA Recommends a Change to the Terms of the Marketing Authorisation for Mosunetuzumab
5 days ago
It adopted a new route for administration along with a new pharmaceutical...
Combining Niraparib with Abiraterone Acetate and Prednisone Significantly Improves rPFS in Patients with mCSPC Harbouring BRCA1/2 or Other HRR Gene Alterations
6 days ago
Findings from the AMPLITUDE study
Aiming to Prevent New Cancer Cases, ESMO Calls for Increased Minimum EU Excise Duty Rates on Tobacco Products in its Response to the Public Consultation on the Tobacco Taxation Directive
8 days ago
With tobacco taxation being recognised by both the World Health Organization (WHO)...
ESMO Publishes First Guidance on the Safe Use of Large Language Models in Oncology Practice
10 days ago
New framework aims to help patients, clinicians and institutions adopt AI language...
New Generation of Antibody-Drug Conjugates (ADCs) Shows Unprecedented Promise in Early-Stage Disease
10 days ago
In a landmark moment at the ESMO Congress 2025, pivotal studies have...
Study Shows Thymic Health is Linked to Cancer Patients’ Response to Immunotherapy
11 days ago
The health of the thymus – a key part of the body’s...
FDA Approves Lurbinectedin in Combination with Atezolizumab or Atezolizumab and Hyaluronidase-tqjs for Extensive Stage SCLC
12 days ago
Evidence for efficacy is based on the results from the IMforte study
Outcome of EMA Assessment on Use of Lutetium (177Lu) in Treatment of GEP-NETs in Adolescents
13 days ago
Although EMA did not recommend this use, it agreed that relevant data...
Treatment Guided by Comprehensive Genomic Profiling and Expert MTB Decision-Making Improves Outcomes in Pretreated Patients with Metastatic Cancer
14 days ago
Findings from the ROME study
ESMO 2025: A Glimpse Into the Congress Programme, Berlin, Germany, 17-21 October
15 days ago
The ESMO Congress 2025 will take place from 17-21 October in Berlin...